Peer-reviewedCC BY 4.0eClinicalMedicine
The use of appropriate, inappropriate and no comparators in efficacy trials for European Medicines Agency-approved drugs 2011–2024: a retrospective cohort study
Related
- Selecting Vehicle Comparators in Dry Eye Disease Clinical Trials: Implications for Efficacy and Safety Assessment and Regulatory Outcomes
- Sex representation and assessment of sex-related differences in central nervous system medicine development: a retrospective cross-sectional study of European Medicines Agency marketing authorisation dossiers (2012–2022)
- Toxic traditional Chinese medicines as hormetic immunomodulators in cancer: from toxicity-efficacy homology to translational opportunities
- Effect of inappropriate empirical antimicrobial therapy on time to hospital discharge in patients with community-acquired acute pyelonephritis: a propensity score-weighted retrospective cohort study.
- Association between health empowerment and medication literacy among older adults with coronary heart disease after PCI: the mediating role of self-efficacy for appropriate medication use
BibTeX
@article{glaus2026appropriate,
title = {{The use of appropriate, inappropriate and no comparators in efficacy trials for European Medicines Agency-approved drugs 2011–2024: a retrospective cohort study}},
author = {Camille E.G. Glaus and Cascal Herrle and Simon Hediger and Kerstin Noelle Vokinger},
journal = {eClinicalMedicine},
year = {2026},
month = nov,
doi = {10.1016/j.eclinm.2026.104319},
url = {https://linkinghub.elsevier.com/retrieve/pii/S2589537026005729},
note = {CC BY 4.0},
}
RIS
TY - JOUR
TI - The use of appropriate, inappropriate and no comparators in efficacy trials for European Medicines Agency-approved drugs 2011–2024: a retrospective cohort study
AU - Camille E.G. Glaus
AU - Cascal Herrle
AU - Simon Hediger
AU - Kerstin Noelle Vokinger
PY - 2026
DA - 2026/11/01
JO - eClinicalMedicine
DO - 10.1016/j.eclinm.2026.104319
UR - https://linkinghub.elsevier.com/retrieve/pii/S2589537026005729
SN - 2589-5370
ER -